OTC Drug Review’s Constitutionality Questioned By CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency